KIT and gastrointestinal stromal tumor: Previously, we identified similar genes and pathways that might drive GIST tumor malignancy by transcriptome analysis of KIT+ cells isolated from 4 metastatic, imatinib-resistant tumors and 8 primary, untreated tumors [19].